MidDiagnosed 2026-10-19 12:13:11 KSTJJNJAI Stock Diagnostic ReportJ&J’s Tremfya shows maintained fistula remission in Crohn’s trialPositive clinical results indicating that Tremfya demonstrates a maintenance effect on Crohn's disease fistula closure are a positive factor for the stock price.View Source Article ↗ AI CATALYST SCORE68 / 100Score computed by Sentinel V12REFERENCE PRICENot measuredReference entry price at analysis time 👍 0🔥 0🤔 0🔗 0𝕏f🔗📤